| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lineage Cell Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 650,000 | 10 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics, Inc. | 10 Mar 2022 | 1 | $0 | 4 | Chief Financial Officer | 11 Mar 2022, 19:42 |
| LCTX | Lineage Cell Therapeutics, Inc. | 11 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 15 Feb 2022, 18:40 |
| LCTX | Lineage Cell Therapeutics, Inc. | 21 Jun 2021 | 1 | $0 | 4 | Chief Financial Officer | 01 Jul 2021, 16:21 |
| LCTX | Lineage Cell Therapeutics, Inc. | 21 Jun 2021 | 0 | $0 | 3 | Chief Financial Officer | 01 Jul 2021, 16:15 |